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Abstract: Control of cell migration is fundamental to the performance of materials for cell delivery,
as for cells to provide any therapeutic effect, they must migrate out from the delivery material.
Here the influence of fibrinogen concentration on the migration of encapsulated human mesenchymal
stem cells (hMSCs) from a cell spheroid through fibrin hydrogels is tracked over time. Fibrin was
chosen as a model material as it is routinely employed as a haemostatic agent and more recently has
been applied as a localised delivery vehicle for potential therapeutic cell populations. The hydrogels
consisted of 5 U/mL thrombin and between 5 and 50 mg/mL fibrinogen. Microstructural and
viscoelastic properties of different compositions were evaluated using SEM and rheometry. Increasing
the fibrinogen concentration resulted in a visibly denser matrix with smaller pores and higher
stiffness. hMSCs dispersed within the fibrin gels maintained cell viability post-encapsulation,
however, the migration of cells from an encapsulated spheroid revealed that denser fibrin matrices
inhibit cell migration. This study provides the first quantitative study on the influence of fibrinogen
concentration on 3D hMSC migration within fibrin gels, which can be used to guide material selection
for scaffold design in tissue engineering and for the clinical application of fibrin sealants.
Keywords: fibrin hydrogels; 3D cell migration; stem cells; cell delivery; regenerative medicine
1. Introduction
Hydrogels, highly hydrated cross-linked polymers, are increasingly sought as tissue engineering
scaffolds due to their hydrophilicity, permissive nutrient/waste exchange, and predisposition
for biocompatibility [1,2].
Fibrin, a protein biopolymer that simulates the final stage of the coagulation cascade, is routinely
employed as a haemostatic agent [3]. The polymer network is generated following addition of
thrombin, a serine protease, to the 45 nm monomer fibrinogen [4]. Fibrin is used in augmenting
wound healing, and is increasingly used to promote angiogenesis [5], to release drugs and growth
factors [6], and as a mode for cell delivery [3,7], with commercial fibrin sealants used to encapsulate
cells for delivery [8–10]. Encapsulation within a gel for delivery into the body is an attractive option
as it allows cells to be positioned within the body, and temporarily retained in position, but in order
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for the cells to offer a therapeutic effect they need to then migrate out of the gel and interact with
native tissue. Adipose-derived human mesenchymal stem cells (hMSCs) have been delivered in
fibrin to augment microfracture procedures in cartilage regeneration [11], with histological evaluation
demonstrating superiority over the microfracture-only procedure. hMSCs are commonly identified as
cells of particular interest for tissue engineering [12,13].
Fibrin’s non-toxic biodegradability, abundance, low cost, potential for autologous origin,
and adjustable mechanical and physical properties gives the material some advantages over other
hydrogels [3]. The diverse adoption of fibrin hydrogels testifies to their versatility with applications in
musculoskeletal [14–16], skin [17], cardiovascular [18,19], neural [20], and ocular [21,22] tissue engineering.
Conventional migration assays are constrained by their two-dimensionality [23]. Often composed
of cells cultured as a monolayer upon the investigated substrate, these assays provide a simplified
overview of in vivo cell migration with ensuing disparities when translating research into the clinic [24].
Migration studies on 2D substrates and/or tissue culture plastics introduces a number of artificial
elements including high stiffness, cell contacts restricted to x- and y-planes, abnormal polarisation,
and the absence of biophysical impediments found in native tissue [25]. Indeed, a growing body
of work attests to distinct mechanical, physical, and biochemical processes that occur in a 3D
microenvironment [26–28]. Research into simulating in vivo cell migration has highlighted the diverse
modes of migration for different cell types according to their anatomical location and physiological
role [24]. Generally, cells migrate in a phased process involving: (1) polarisation inducing the formation
of a leading edge comprising cytoskeletal projections, (2) attachment onto the matrix and maturation
of cell-matrix interactions, and (3) detachment at the posterior to move forward [24,29]. Moreover,
migration through matrices featuring physical impediments requires an adjustment in cell shape,
proteolytic degradation, and/or subsequent cell-mediated remodelling of the microenvironment [25].
With respect to fibrin, modification of precursor concentrations alters the hydrogel architecture
which consequently affects the rate of migration; encapsulated cells migrate by physically advancing
through size-permitting pores or secreting enzymes such as matrix metalloproteinases (MMPs) to
remodel the matrix [30–32]. As a protein, fibrin undergoes degradation, principally by way of plasmin
and MMP activity [25,33]. In general, gelation kinetics determines gel structure which can be configured
by adjusting concentrations of fibrinogen [34], thrombin [35], and Ca2+ [36], Factor XIIIa [37], the local
ionic strength, pH, and temperature [38,39]. Differing views exist regarding the extent to which the
aforementioned factors induces the greatest effect on gel structure and consequently, cell behaviour
including viability, proliferation, and migration. Nevertheless, the predominant role of fibrinogen
concentration has been well-documented [7,34,40].
Although there has been considerable investigation into fibrin hydrogel-encapsulated cells, little
information on 3D cell migration is available. Earlier research into migration and fibrin aimed
to further understanding of the wound healing process [41,42]. In these investigations, cultured
monolayers on fibrin substrates were incised as characteristic of a scratch assay to assess migration.
Of relevance, Schleef et al. highlighted the influence of fibrinogen concentration on endothelial
cell migration [42], noting that 2D migration was reduced as fibrinogen concentration increased.
Other studies have encapsulated cells within 3D fibrin gels and examined cell outgrowth into the
surrounding tissue culture plastic [34,43]. While cells were surrounded in a fibrin matrix, these studies
nevertheless investigated migration from a 3D gel onto a 2D well plate. Recently, Hakkinen et al.
assessed the migration of encapsulated neurites within four 3D ECMs including fibrin gels [44],
and Nandi and Brown [45] assessed the effect of pro- and anti-migratory factors on fibroblast migration
from encapsulated spheroids. However, in both cases gel formulations were kept constant and thus,
no examination on the effect of precursor concentrations was carried out. Interestingly, increasing
fibrinogen concentration reduced neurite extension from dorsal root ganglions embedded in fibrin
gels [46]. The researchers underlined the impact of fibrin’s physical properties including gel stiffness
and porosity—both concomitant factors in cell migration—on neurite extension.
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In 2D studies of MSC behaviour using different concentrations of fibrinogen and thrombin,
both Ho et al. [40] and Hale et al. [47] found that the MSC proliferation rate was affected by fibrinogen
and thrombin concentrations, finding that cells proliferate faster with dilute fibrinogen solutions.
Similarly, Catelas et al. analysed MSC behaviour (morphology, proliferation and differentiation)
at eight different fibrin concentrations [48]. However, in both studies migration rates were not
investigated. The aim of the work reported here was to systematically assess the ability of hMSCs
to migrate within 3D fibrin hydrogels in order to inform clinical practice, specifically on the use of
fibrin sealants for cell delivery, and in addition to illustrate the value of 3D migration models as a gel
formulation optimisation tool for tissue engineers.
2. Materials and Methods
2.1. Fibrin Gel Preparation and Synthesis
Fibrin gels were prepared from plasma-derived bovine fibrinogen (341573, Merck Millipore,
Watford, UK) and bovine thrombin (605157, Merck Millipore, Watford, UK). Broadly, fibrinogen was
reconstituted in Hank’s buffer salt solution while thrombin was reconstituted in a diluent solution
comprising hMSC cell culture media (with composition as described in Section 2.4) modified to contain
20 mM calcium chloride. All components were pre-warmed to 37 ◦C and gently mixed to ensure
complete solubilisation.
Fibrin gels with final concentrations of 5 mg/mL to 50 mg/mL fibrinogen and 5 U/mL thrombin
were used, based on concentrations used in the literature and to give a good range of properties. Fibrin
formation was initiated by mixing fibrinogen at the different concentrations and thrombin in equal
volumes before allowing for gelation at 37 ◦C/5% CO2 in a humid atmosphere for 1 h. Depending
on the characterisation, materials were prepared using one of three different procedures (outlined
schematically in Figure 1):
(a) A total of 200 µL of formed fibrin gel material was deposited on borosilicate glass coverslips for
the physical-chemical characterisations.
(b) For the different cellular studies, cells were added within thrombin solution and fibrin gels
containing 25,000 cells/gel were formed on 13 mm diameter circular borosilicate glass coverslips
(631-0159, VWR, Lutterworth, UK).
(c) For cell migration experiments, cellular spheroids (50,000 cell) were encapsulated within fibrin
gels in multi-wells.
Glass coverslips were plasma treated by using a PDC-32G plasma cleaner (Harrick Plasma,
Ithaca, NY, USA) for an improved surface wettability and subsequently sterilised under UV light at
254 nm for 30 min. Each experiment was performed in triplicate.
2.2. ScanningElectron Microscopy
Formed fibrin gels were washed in distilled water thrice for 15 min each to remove excess salt and
fixed in 2.5% glutaraldehyde (v/v) in phosphate buffer saline (PBS) solution for 2 h at 4 ◦C. Gels were
dehydrated in a graded series of 50%, 75%, and two 100% (v/v) ethanol/distilled water solutions for
15 min each. Dehydrated gels were placed in a Baltec CPD 030 critical point dryer (Leica Microsystems,
Milton Keynes, Watford, UK) to replace ethanol with liquid CO2 before removal. Once dried, gels
were mounted on aluminium stubs, sputter-coated with approximately 10 nm gold using a Polaron
E5000 sputter coater (Quorum Technologies, Laughton, UK), and observed under a Tescan VEGA
LMU SEM microscope (Tescan, Cambridge, UK) with an accelerating voltage of 8.0 kV and working
distance of 8–10.0 mm. Images were then analysed using ImageJ. Images at 25 k magnification were
divided into four quadrants, and within each quadrant three representative fibre or pore diameters
were measured. Two images for each fibrinogen concentration were assessed giving 24 measurements
for statistical analysis.
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Figure 1. Schematic overview of fibrin formation for (a) material characterisation experiments,
(b) encapsulated hMSCs in fibrin gels, and (c) encapsulated hMSC spheroids in fibrin gels for migration
experiments. Fibrin gels were formed by mixing fibrinogen (red) and thrombin (blue) in equal volumes
on parafilm before deposition onto glass coverslips (a,b) or tissue culture plastic (c). Once formed,
gels were allowed to gelate at 37 ◦C/5% CO2 for 1 h before addition of media.
2.3. Rheological Characterisation
The viscoelastic properties of the fibrin gels on glass coverslips were determined using a Malvern
Kinexus pro + rotational rheometer (Malvern Instruments Ltd., Malvern, UK) configured with a parallel
plate geometry (20 mm upper platen with a measuring gap of approximately 1.5 mm, preloaded to
0.1 N). Temperature was maintained with a high temperature cartridge at 37 ◦C while evaporation
was controlled with a solvent trap filled with distilled water. Oscillatory experiments were performed
with strain sweeps (0.01–100% strain, 1 Hz) to assess the rheological properties of the gels.
2.4. Cell Culture
Immortalised TERT-hMSCs. developed at the University of York (Y201 line, as described in [49]) were
used as they provide a consistent source of hMSCs for experimentation. The cells were routinely cultured
in Dulbecco’s modified Eagle’s medium with 1 g/L glucose (BE12-707F, Lonza, Slough, UK) supplemented
with 10% (v/v) foetal bovine serum (Gibco A3160402, ThermoFisher Scientific, Loughborough, UK),
1% (v/v) penicillin and streptomycin (P4333, Sigma Aldrich, Gillingham, UK), and 5 mM L-glutamine
(G7513, Sigma, Gillingham, UK). Cells were maintained from passage 76 in routine cell culture at
37 ◦C/5% CO2, and were passaged when judged to be 70–80% confluent.
2.5. Live/Dead Cell Staining
The morphology and viability of hMSCs encapsulated in fibrin gels (25,000 cells/gel) was
assessed using live/dead cell staining to visualize the viable (green) and dead (red) cells. Cells
grown on glass coverslips (25,000 cells/coverslip) served as a control. Six hours after gelation,
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cell-laden fibrin gels were washed in PBS for 30 min before incubation with 100 µL of live/dead
stain containing 2 µM calcein-AM and 4 µM ethidium homodimer-1 (Thermo Fisher Scientific,
Loughborough, UK) for a further 30 min. Gels were incubated at 37 ◦C/5% CO2 during washing
and incubation. Following incubation, cell-laden fibrin gels were imaged under a Leica M165 FC
stereo microscope (Leica Microsystems, Milton Keynes, UK) at 100× magnification; calcein-AM was
examined at BP 450–490 nm excitation and LP 515 nm emission, ethidium homodimer-1 was examined
at BP 515–560 nm excitation and LP 590 nm emission. Representative images were acquired with LAS
Core software (Leica Microsystems, Milton Keynes, UK) at the center and edges of each gel (images
taken at day 0 with 3 samples per concentration).
2.6. PrestoBlue® Cell Viability Reagent
The proliferation of hMSCs in fibrin gels (25,000 cells/gel) over time was quantified by
adding 200 µL PrestoBlue® cell viability reagent to each gel; cells grown on glass coverslips
(25,000 cells/coverslip) served as a control. Viability measurements were taken following
manufacturer’s instructions, briefly, media was replaced with a 10% PrestoBlue® in media solution
and incubated for 2 h at 37 ◦C/5% CO2. Following incubation, readings were taken at 560 nm
excitation and 590 nm emission using a Perkin Elmer LS 50 B luminescence spectrometer (Perkin Elmer,
Seer Green, UK) at day 1, 3, and 7. The PrestoBlue® solution was then aspirated and fibrin gels were
washed in PBS twice for 10 min before replacement with media and incubated at 37 ◦C/5% CO2
until the next required reading. Readings taken were standardised against the media control before
estimation of cell number using calibration curves obtained using manufacturer’s instructions.
2.7. Spheroid Outgrowth Studies
The migration potential of hMSC spheroids (50,000 cells) within fibrin gels was monitored with
time-lapse microscopy. Briefly, a bilayer setup was used in which an initial 200 µL gel was deposited
into a 48 well plate and allowed to gelate (Figure 1c). Spheroids were generated following an adapted
micro-mass method from Ahrens et al. [50] in agarose [51]. 1.5% agarose gels were prepared and
autoclaved prior to pipetting 50 µL/well into flat bottom wells. After further sterilization under UV for
30 min a 50 µL cell suspension in hMSC media (as defined in Section 2.4) containing 50,000 cells was
added to each well. Cells were then cultured at 37 ◦C/5% CO2 for 72 h to allow the spheroid to form.
The spheroids were then embedded into 200 µL of fibrin gel which was deposited onto the initial base
gel, followed by incubation at 37 ◦C/5% CO2 for a further 1 h. Spheroid outgrowth was monitored
with a Nikon TiE inverted microscope equipped with a Nikon DS-Fi2 camera head (Nikon Instruments,
Kingston upon Thames, UK) and a cage incubation system (Okolab, Pozzuoli, Italy) to provide
environmental control at 37 ◦C/5% CO2. Images were acquired with Nikon NIS Elements software
(Nikon Instruments) at 40× magnification in 1 h intervals for 72 h and analysed using ImageJ 1.50i
(National Institute of Health, Bethseda, Maryland, USA) equipped with the LOCI Bio-Format plugin.
A migration index was calculated for each individual spheroid examined as follows:
Migration index =
Total area− spheroid core area
Total area
(1)
2.8. Statistical Analysis
Quantitative data were statistically analysed using GraphPad Prism (GraphPad, Version 6.01,
La Jolla, CA, USA). Data were assessed for normality prior to performing one-way (repeated
measures where required) or two-way analysis of variance (ANOVA) with Tukey’s and Sidak’s
test for comparison. Significance was set at p ≤ 0.05 (*), p ≤ 0.01 (**) and p ≤ 0.001 (***).
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3. Results
3.1. SEM Analysis
SEM micrographs were obtained of fibrin gels comprising 5, 20, and 50 mg/mL fibrinogen,
and were analysed to assess fibre and pore sizes (Figure 2). The higher fibrinogen concentrations
resulted in increased fibre density with smaller average pore sizes when compared to the more open
structure depicted at the lowest fibrinogen concentration. The diameter of the nanofibres did not vary
with fibrinogen concentration.
Figure 2. (a) Representative SEM micrographs of fibrin gels comprising 5, 20, and 50 mg/mL fibrinogen,
and 5 U/mL thrombin at 10 K and 25 K magnification. Scale bars at 10 K magnification represent 5 µm;
scale bars at 25 K magnification represent 2 µm. (b) Fibre diameter and (c) pore diameter distributions
estimated from image analysis on two representative images. p ≤ 0.001 (***).
3.2. Viscoelasticity of Fibrin Gels
The rheological results were consistent, with variations between replicates of less than 5%.
Across the range of fibrinogen concentrations, the storage/elastic modulus (G’) was greater than
the loss/viscous modulus (G”) until gel disintegration, indicating the elastic behaviour of fibrin gels
(Figure 3). The G’ of the fibrin gels increased non-linearly with fibrinogen concentration, with a more
marked increase from 5 mg/mL to 20 mg/mL than from 20 mg/mL to 50 mg/mL. In general, moduli
appeared stable up until around 1% strain, which determined the linear viscoelastic region prior to
this value.
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3.3. Viability and Morphology of hMSCs within Fibrin Gels
The viability and morphology of hMSCs within fibrin gels at initial encapsulation was assessed
after 6 h (Figure 4). For each concentration, cells displayed low cytotoxicity, good viability and an even
distribution within the gels. Cells within the centre of fibrin gels at lower fibrinogen concentrations
(5 mg/mL and 10 mg/mL) displayed an elongated, spindly morphology, similar to the glass control,
as opposed to the smaller, rounder appearance found at higher concentrations. At the edges of the
gels, cells also exhibited an elongated morphology at higher fibrinogen concentrations.
Figure 3. Representative strain sweeps of fibrin gels comprising 5 (circles), 20 (square), and 50 mg/mL
(triangles) fibrinogen and 5 U/mL thrombin. Filled symbols indicate storage modulus (G’) and hollow
symbols indicate loss modulus (G”).
3.4. Encapsulated hMSC Proliferation
The numbers of encapsulated hMSCs in fibrin gels was assessed over a 7-day period (Figure 5).
No significant differences in cell number were observed at day 1 or day 7. At day 3, for all samples
excluding those made with 40 mg/mL and 50 mg/mL fibrinogen, cell numbers had approximately
doubled from day 1.
3.5. Encapsulated hMSC Migration
Figure 6 shows representative images from the spheroid outgrowth experiements, and Figure 7
quantifies the results. Gels composed of 5 mg/mL to 20 mg/mL fibrinogen showed outgrowth at day 1,
whereas spheroids in gels at 40 mg/mL and 50 mg/mL fibrinogen exhibited no outgrowth at this point.
At day 3, gels comprising fibrinogen concentrations from 5 mg/mL to 30 mg/mL allowed a marked
increase in hMSC migration compared to day 1. In particular, fibrin gels at 5 mg/mL presented
a five-fold increase in outgrowth at day 3 which paralleled a notable reduction in spheroid core size.
Spheroid outgrowth was observed at higher concentrations, although this was more limited. In all,
results from the migration experiments demonstrated that increasing fibrinogen concentration in gels
reduced the migratory capacity of encapsulated hMSCs.
4. Discussion
4.1. Fibrinogen Concentration Influenced Gel Structure
The 5% fibrinogen concentration resulted in a significantly increased average pore size when
compared to the 20% and 50% concentrations (Figure 2). Higher fibrinogen concentrations provide
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more substrate for thrombin and thus increase fibre density, thought to be due to the presence of more
fibres as opposed to an increase in the occurrence of branching [52]. The estimated fibre diameters
are in line with previous fibre quantification studies for these concentrations of fibrinogen [52],
thrombin [35,53], and Ca2+ [54], and overall the observation would be that, within the scope of
this experimental study, varying the fibrinogen concentration primarily affects pore size, but that this
is not a linear relationship.
Figure 4. Representative images, at the center and edge, of cell-laden fibrin gels stained with
calcein-AM (green) and ethidium homodimer-1 (red) (live/dead). Fibrin gels comprised 5, 10, 20, 30,
40, and 50 mg/mL fibrinogen and 5 U/mL thrombin. Cells seeded onto borosilicate glass coverslips
served as controls. Scale bar equates to 200 µm.
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Figure 5. Proliferation of hMSCs within fibrin gels at day 1 (black), 3 (light grey), and 7 (dark grey) as
quantified by PrestoBlue® cell viability assay. Fibrin gels comprised 5, 10, 20, 30, 40, and 50 mg/mL
fibrinogen and 5 U/mL thrombin. Data is expressed as mean ± SD (n = 3). * p < 0.05, ** p < 0.01 to the
glass coverslip control.
Figure 6. Representative images of spheroid outgrowth at day 0, 1, and 3. Gels comprised 5, 10, 20, 30,
40, and 50 mg/mL fibrinogen and 5 U/mL thrombin. Red dashed line approximates outgrowth at the
greatest extent. Scale bar equates to 200 µm.
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Figure 7. Migration index, at day 1 and 3, of hMSC spheroids within fibrin gels comprising 5, 10, 20,
30, 40 and 50 mg/mL fibrinogen and 5 U/mL thrombin. Migration index calculated as the total area
subtracted by spheroid outgrowth area. Data represents mean ± SD (n = 3), ** p < 0.01, *** p < 0.001 to
50 mg/mL at respective time points.
4.2. Rheological Characterisation of Fibrin Gels
Higher concentrations of fibrinogen produced more rigid gels (Figure 3), with the relationship
between G’ and fibrin concentration approximately linear. This concentration-dependent stiffness has
been corroborated at lower [52] and higher [14] fibrinogen concentrations, and is thought to be caused
by the increase in fibre density and general protein mass rather than a result of changes in individual
fibre structure [52].
4.3. Cytocompatibility of Fibrin Gels
Live/dead staining demonstrated high cytocompatibility during initial cell dispersion (Figure 4).
While viability was unchanged at different fibrinogen concentrations, divergent cell morphologies
appeared between gels at low and high fibrinogen concentrations—a distinction that has been
previously demonstrated with bone marrow stromal cells [16,40], and lipoaspirate-derived hMSCs [55].
Overall cells exhibited greater spread at the edges of gels, and in the centre of gels for the lower
concentrations (notably for 5 mg/mL fibrinogen, but to a lesser extent for 10 mg/mL fibrinogen).
The concentration dependent element of this is considered simply to be that the lower concentrations
of fibrinogen allow cells to be more mobile and to spread out more easily. The reason for the edge
effect is less clear, but at the edges of the gels there is a greater surface area in contact with media
relative to the volume of gel. This means that:
(a) Cells at the edge could be able to obtain more nutrients and oxygen via diffusion and mass
transport as a result [27], thus making them more mobile.
(b) Greater diffusion of media into the gels at the edge may make the gels locally less stiff, and allow
greater spreading, possibly accentuated through cells accessing plasmin, allowing for some
matrix remodelling.
Whilst of note the effect was not significant in terms of cytocompatibility, as at the centre of the
gels all the gel concentrations showed excellent cytocompatibility.
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4.4. Spheroid Outgrowth Experiments
Increasing fibrinogen concentration clearly diminished cell migration (Figure 7). The reduced
migration at higher fibrinogen concentrations is considered to be primarily related to the confined
porosity observed in these gels. Transmigration investigations within collagen have indicated the
prominence of porosity in allowing fibrosarcoma cell migration [56], with peak migration occurring
when pore size correlated with the cell body, with restrained migration contingent on pores that prevent
nuclei from traversing through fibre networks [56,57]. Although these studies were performed within
collagen gels, similarities in gel structure are observed with fibrin as both are fibrous protein-based 3D
ECMs. The nuclei of the hMSCs used in this study are of the order of 10 µm diameter, and consideration
of Figure 2 would then suggest that the cells can more easily make progress through a loose network
with pores of around 2–5 µm across (5 mg/mL fibrinogen), than a tighter network with pores which
are predominantly below 1 µm across (20 and 50 mg/mL fibrinogen). The center images in Figure 3
show that at the 5 mg/mL fibrinogen gel allowed cell spreading throughout the gel, which means
that the cell migration process of cytoskeletal projection, followed by attachment onto the matrix,
followed by posterior detachment [24,29] is much easier at that concentration. With easier cytoskeletal
projection, and more space to move in, we assume that cells are able to “pull” their way through the
fibre matrix at a much quicker rate.
The restricted migration at high fibrinogen concentrations has implications for tissue engineers
who use commercial fibrin sealants for cell encapsulation. Products such as Tisseel® are often used
by surgeons, but their composition has a fibrinogen concentration in excess of 50 mg/mL. On the
basis of the data presented here, these materials will not support the migration of encapsulated cells
through the bulk material, with concentrations of 5 mg/mL or 10 mg/mL fibrinogen much better
able to support migration. Sealants produced with higher fibrinogen concentrations can be used to
immobilise cells or delay migration. Interestingly Hale’s et al. [46] 2D migration study with fibrin gels
indicated that a fibrinogen concentration of 50 mg/mL was a threshold below which high magnitude
migration could occur. This suggests that migration through a porous 3D network is significantly
underestimated by 2D cell outgrowth models, and means that models of the type presented here offer
a useful tool in determining hydrogel formulation for cell carrier applications.
4.5. Limitations of the Current Study
The characterisation of outgrowth within this paper has been through assessing the extent of
maximum outgrowth, as interpreted from a 2D image of a 3D outgrowth model, so whilst the model is
3D the interpretation remains 2D. Other authors have characterized the outgrowth area [45], again
from a 2D image of a 3D outgrowth model, and image analysis tools could provide a wide range of
potential measures of outgrowth, including, for example, cell migration speed. Figure 6 shows that for
this study the extent of maximum outgrowth seems representative of overall outgrowth, but image
analysis could aggregate individual cell behaviour to produce a more detailed measurements than the
technique used here, which could potentially be biased by the most active cell. The various parameters
which could be used to interpret outgrowth images all offer different views of the same underlying
process, and each will have advantages and disadvantages depending upon the intended application
of the cell/gel construct. However, a key advantage of this type of model is that it gives a systematic,
quantitative outcome which allows for lab to lab comparisons of cell behaviour in 3D environments.
Further work with the outgrowth model will extend the technique to assess further materials for cell
carrier applications, in particular for bio-ink formulation for 3D bioprinting, and will assess the value
of different parameters for characterizing outgrowth.
5. Conclusions
This study has used a spheroid outgrowth model to provide clear and quantified information
on the mobility of cells within fibrin gels, and we consider that the spheroid outgrowth model offers
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an excellent tool for the assessment of cell migration. The inverse relationship between fibrinogen
concentrations and migration of encapsulated hMSCs within 3D fibrin gels has been previously
reported, but not previously quantified in a way which gives clear guidance on gel formulation.
The relationship has implications for scaffold design strategies and in clinical settings with use of fibrin
sealants. Cell migration requires both cytoskeletal projection and sufficient space for cells to move into,
and decreasing fibrinogen concentration produced fibrin gels with larger pores and lower density and
stiffness, thus enabling quicker cell migration.
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